MYELOFIBROSIS (PMF)
Clinical trials for MYELOFIBROSIS (PMF) explained in plain language.
Never miss a new study
Get alerted when new MYELOFIBROSIS (PMF) trials appear
Sign up with your email to follow new studies for MYELOFIBROSIS (PMF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for Tough-to-Treat blood cancer patients
Disease control Recruiting nowThis study is testing whether an oral medication called reparixin can help control advanced myelofibrosis, a serious bone marrow cancer. It's for patients whose disease has worsened despite standard treatments or who cannot take those treatments. Researchers will measure if the d…
Matched conditions: MYELOFIBROSIS (PMF)
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Massive 5,000-Person study launches to map the journey of rare blood cancers
Knowledge-focused Recruiting nowThis is a long-term observational study aiming to better understand a group of rare, chronic blood cancers called myeloproliferative neoplasms (MPNs). It will follow 5,000 adults in the U.S. who have been diagnosed with an MPN for at least five years, collecting information from …
Matched conditions: MYELOFIBROSIS (PMF)
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC